Use of protease inhibitors among persons with AIDS in Los Angeles County (Q38499230)

3 September 2017

Use of protease inhibitors among persons with AIDS in Los Angeles County (English)

1 reference

3 September 2017

Sorvillo F

1

1 reference

3 September 2017

Kerndt P

2

1 reference

3 September 2017

Odem S

3

1 reference

3 September 2017

Castillon M

4

1 reference

3 September 2017

Carruth A

5

1 reference

3 September 2017

Contreras R

6

1 reference

3 September 2017

1 April 1999

1 reference

3 September 2017

1 reference

3 September 2017

11

1 reference

3 September 2017

2

1 reference

3 September 2017

147-155

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

3 September 2017

1 reference

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Two studies of compliance with daily prophylaxis in rheumatic fever patients in Iowa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Modeling and variable selection in epidemiologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Evidence for recent growth of the HIV epidemic among African-American men and younger male cohorts in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Inequities in health services among insured Americans. Do working-age adults have less access to medical care than the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

The impact of confounder selection criteria on effect estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Racial differences in the use of drug therapy for HIV disease in an urban community

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

Access to prenatal care following major Medicaid eligibility expansions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540129948045

21 January 2018

Identifiers

DOI

10.1080/09540129948045

1 reference

3 September 2017

1 reference